Clover Health Investments (CLOV) Long-Term Investments (2020 - 2026)

Clover Health Investments (CLOV) has 7 years of Long-Term Investments data on file, last reported at $241.3 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments rose 1593.97% year-over-year to $241.3 million; the trailing twelve-month figure through Mar 2026 stood at $241.3 million (up 1593.97% YoY), and the FY2025 full-year result was $224.0 million, up 11.07% from the prior year.
• Long-Term Investments for Q1 2026 stood at $241.3 million, up from $224.0 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $310.5 million in Q3 2023 and bottomed at $742000.0 in Q4 2022.
• The 5-year median for Long-Term Investments is $158.7 million (2022), against an average of $133.8 million.
• The widest annual swing landed in 2022, when Long-Term Investments slumped 99.63%; it then soared 16100.54% in 2023.
• A 5-year view of Long-Term Investments shows it stood at $742000.0 in 2022, then jumped by 16100.54% to $120.2 million in 2023, then jumped by 67.81% to $201.7 million in 2024, then rose by 11.07% to $224.0 million in 2025, then increased by 7.72% to $241.3 million in 2026.
• The last three Long-Term Investments figures came in at $241.3 million (Q1 2026), $224.0 million (Q4 2025), and $180.7 million (Q3 2025), per Business Quant data.

Peer Comparison